Disclaimer: This is a user generated content submitted by a member of the WriteUpCafe Community. The views and writings here reflect that of the author and not of WriteUpCafe. If you have any complaints regarding this post kindly report it to us.

The rising cases of diabetes in patients will create new growth opportunities for the Global Diabetes Monitoring Devices Market, says Fortune Business Insights in a report, “Diabetes Monitoring Devices Market Size, Share and Industry Analysis by Product (Blood Glucose Meters, Test Strips, Lancets), Distribution Channel (Institutional Sales, Retail Sales) & Regional Forecast, 2019 – 2026.” The global diabetes monitoring devices market was valued at USD 21,614.7 Million in 2018, is expected to reach USD 32,881.9 Million by 2026, exhibiting a CAGR of 5.4%.

For more information in the analysis of this report, visit: https://www.fortunebusinessinsights.com/industry-reports/diabetes-monitoring-devices-market-100529

Detailed Table of Content:

  1. Introduction

1.1. Research Scope

1.2. Market Segmentation

1.3. Research Methodology

1.4. Definitions and Assumptions

  1. Executive Summary
  2. Market Dynamics

3.1. Market Drivers

3.2. Market Restraints

3.3. Market Opportunities

  1. Key Insights

4.1 Prevalence Of Diabetes By Key Countries

4.2 Pricing Analysis, By Key Regions

4.3 Technological Advancements

4.4 Recent Industry Developments, Mergers & Acquisitions


Related Press Release:

Hip Replacement Market

Connected Drug Delivery Devices Market

Dermal Fillers Market

Medical Devices Market

Blood Pressure Monitors Market

Guidewire Market

Hyaluronic Acid Based Dermal Fillers Market

Surgical Sutures Market

Diabetes Monitoring Devices Market

Key Industry Developments

  • In May 2019, Lifespan Inc., had an exclusive agreement with Sanvita Medical, LLC., a subsidiary of Nova Biomedical Corporation to market continuous glucose monitoring (CGM) sensors. This collaboration has planned the launch CGM systems in North America and select countries in Europe.
  • In July 2016, ACON Laboratories, Inc., launched New On Call pro blood glucose meter for multi-patient use. This launch in the US has made the blood glucose testing in the hospitals easier.
  • In March 2016, ACON Laboratories, Inc., launched OptiLance push-button safety lancets. The precision molded needles placed in OptiLance and quality springs prevent any needle chatter confirming optimum comfort for the patient.


Welcome to WriteUpCafe Community

Join our community to engage with fellow bloggers and increase the visibility of your blog.
Join WriteUpCafe